Lv32
294 积分 2022-06-23 加入
PL03.13 Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2)
7天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
7天前
已完结
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
8天前
已完结
Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer
8天前
已完结
Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010–2016 in Sweden: A nationwide observational study
8天前
已完结
Efficacy and safety of denosumab from a phase III, randomized, active-controlled study compared with zoledronic acid in patients of Asian ancestry with bone metastases from solid tumors
1个月前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
1个月前
已完结
Occupational Evaluation of Federal Highway Police Officers Exposed to Cholinesterase Inhibiting Insecticides
2个月前
已关闭
Principles of Cholesteatoma Management
2个月前
已关闭
Prognostic role of EAONO/JOS, STAMCO, and ChOLE Staging for Exclusive Endoscopic and Endoscopic‐Microscopic Tympanoplasty
2个月前
已完结
皖公网安备34019202002308
